Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
113.92
+4.74 (4.34%)
May 1, 2026, 10:43 AM EDT - Market open

Merck & Co. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Period Ending
Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21
Net Income
2,9625,7874,4295,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2523,9494,3073,8244,5717772,749
Depreciation & Amortization
2,4661,1541,1191,0991,1971,1861,1329849641,0149039918929599381,120835759728892
Stock-Based Compensation
205204216195187195203176167164169145145139137120119117123111
Other Adjustments
-512-637-212-1678381,467-147545-582-4015,13226872279677513362343629-320
Changes in Other Operating Activities
-1,314-2,259-3,712-2,582-1,012-3,382-2,177-1,636-2,890-263-1,399-1,299-64-139-1,051-1,641
Operating Cash Flow
2,8577,8223,2932,5003,4509,2915,6373,0902467,7173,7041,3394,4305,6024,3024,7615,0314,7972,1151,791
Operating Cash Flow Growth
-17.19%-15.81%-41.58%-19.09%1302.44%20.40%52.19%130.77%-94.45%37.75%-13.90%-71.88%-11.95%16.78%103.40%165.83%744.13%120.75%3.83%153.32%
Capital Expenditures
-1,033-987-764-1,328-937-783-791-861-989-902-965-1,007-1,149-1,126-1,129-984-1,208-1,172-934-1,082
Purchases of Investments
00-612-595-4550-49-15-151-117-25-562-494-5-333-372000-1
Proceeds from Sale of Investments
46575601456750602601697042855001233537315291110386
Payments for Business Acquisitions
-----200-74600-5,353-1,327-----901-822-
Other Investing Activities
-1721295-20-57233-289-14-21-19-3337-117-4512182-106-1-91-41
Investing Cash Flow
-11,201-283-770-1,487-1,444-3,845-1,069-1,37653-334-11,443-2,359-1,748-962-1,077-1,173-12,049-1,061-1,738-738
Long-Term Debt Issued
7,9185,962--0-11,800-0-72,973---------
Long-Term Debt Repaid
-2-10-2,500-53900-751-3-1-1,750-1-1-1,0000-1,250-2,83300-1,153
Net Long-Term Debt Issued (Repaid)
7,9165,9610-2,500-539-11,800-751-3-81,223-1-1-1,0000-1,250-2,83300-1,153
Issuance of Common Stock
47141219125738767823026510971213417429
Repurchase of Common Stock
-1,252-1,323-1,345-1,164-489-444-251-122-393-466-338-149-----18-583-119.5-
Net Common Stock Issued (Repurchased)
-1,205-1,309-1,333-1,145-477-439-178-35-387-459-256-119265109712116-566-77.59
Common Dividends Paid
-2,018-2,031-2,077-2,050-1,951-1,953-1,986-1,950-1,852-1,855-1,885-1,853-1,750-1,747-1,770-1,745-1,643-1,649-1,673-1,645
Other Financing Activities
-1,897-2,014-2,247-2,110-1,993-1,985-2,206-2,028-1,855-1,865-1,151-1,934-1,818-1,712-1,874-1,848-1,679-1,708-2,293-954
Financing Cash Flow
4,7512,638-3,556-5,755-3,009-2,4251,216-2,814-2,245-4,2693,758-2,054-1,554-2,702-1,777-3,0865,207-2,2742,010-2,098
Effect of Exchange Rate Changes on Cash and Cash Equivalents
2310374156-367294-82-138186-157-9387366-412-309-55-68-4678-97
Net Cash Flow
-3,57010,187-659-4,586-1,3703,3155,702-1,238-1,7602,957-4,074-2,9871,4941,5261,139447-1,8791,4161,619-1,142
Free Cash Flow
1,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,8233,6251,181709
Free Cash Flow Growth
-27.42%-19.66%-47.81%-47.42%-24.84%76.93%571.39%-52.26%-13.68%-91.21%-14.18%23.48%168.67%432.72%-397.94%-13.73%-
FCF Margin
11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%27.56%10.36%6.67%
Free Cash Flow Per Share
0.732.741.010.460.993.351.900.88-0.292.681.080.131.291.761.251.491.511.430.460.28
Levered Free Cash Flow
12,31213,2272,523-1,3623,4646,1416,584752-1,2547,026-6,450-862,7592,3442,3541,8974884,015288195
Unlevered Free Cash Flow
4,7697,0642,5181,1144,1186,0214,8281,480-1,2047,145-7,477-12.122,6973,7382,7443,7713,0603,628-115.83499.25
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q